Connect Biopharma Holdings Ltd (CNTB): Total Assets
$56.08M
As of 2025-12-31
$43.47M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $56.08M | -44.6% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $101.28M | -20.5% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $127.38M | n/a | 2025-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $20.45M | +19.9% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $51.77M | -32.7% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| iBio, Inc. (IBIO) | 2026-06-30 | $99.11M | +327.5% |
Compare CNTB, INO, AVTX, SILO side by side · Screen every company in Pharmaceutical Preparations ↗